CLB-073

N/A

Report date: 2024/08/28 16:26:48
NME

Base Information

Drug NameCLB-073
Drug Alias NameCLB-073CLB073
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenylate cyclase stimulants
TargetsAdenylate cyclase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesCalibr at Scripps Research
China Registration ClassN/A

Develop Information

Active CompaniesThe Calibr-Skaggs Institute for Innovative MedicinesBill & Melinda Gates Medical Research Institute
Inactive CompaniesCalibr at Scripps Research
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A